U.S. approves new Alzheimer's drug developed by Biogen and Eisai Co. U.S. regulators on Monday approved a new drug for Alzheimer's disease developed by Biogen Inc. and Japan's Eisai Co., calling it the first therapy to work on the underlying cause of the illness. The drug, named Aduhelm, is the first new treatment greenlit for Alzheimer's since 2...
5 min read (831 words)
Be the first one to reply with image, gif, video or audio
No information found!!
Watch more stories